89bio (ETNB)
US Market

89bio (ETNB) Stock Price & Analysis


ETNB Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.91 - $20.85
Previous Close$20.16
Average Volume (3M)2.28M
Market Cap
Enterprise Value$1.14B
Total Cash (Recent Filing)$350.93M
Total Debt (Recent Filing)$24.64M
Price to Earnings (P/E)-7.1
Aug 10, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.82
Shares Outstanding72,868,455
10 Day Avg. Volume1,340,758
30 Day Avg. Volume2,281,661
Standard Deviation0.26
Financial Highlights & Ratios
Price to Book (P/B)3.10
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-11.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-10.95
Price Target Upside72.17% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was 89bio’s price range in the past 12 months?
89bio lowest stock price was $2.91 and its highest was $20.85 in the past 12 months.
    What is 89bio’s market cap?
    Currently, no data Available
    When is 89bio’s upcoming earnings report date?
    89bio’s upcoming earnings report date is Aug 10, 2023 which is in 63 days.
      How were 89bio’s earnings last quarter?
      89bio released its earnings results on May 04, 2023. The company reported -$0.54 earnings per share for the quarter, missing the consensus estimate of -$0.522 by -$0.018.
        Is 89bio overvalued?
        According to Wall Street analysts 89bio’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does 89bio pay dividends?
          89bio does not currently pay dividends.
          What is 89bio’s EPS estimate?
          89bio’s EPS estimate is -$0.44.
            How many shares outstanding does 89bio have?
            89bio has 72,868,454 shares outstanding.
              What happened to 89bio’s price movement after its last earnings report?
              89bio reported an EPS of -$0.54 in its last earnings report, missing expectations of -$0.522. Following the earnings report the stock price went up 3.156%.
                Which hedge fund is a major shareholder of 89bio?
                Among the largest hedge funds holding 89bio’s share is RA Capital Management. It holds 89bio’s shares valued at 174M.


                  89bio Stock Smart Score

                  The 89bio stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description


                  89bio, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases. The company was founded on January 01, 2018 and is headquartered in San Francisco, CA.


                  Top 5 ETFs holding ETNB

                  Market Value
                  Smart Score
                  iShares Core S&P Total U.S. Stock Market ETF
                  iShares NASDAQ US Biotechnology UCITS ETF
                  Fidelity Nasdaq Composite Index ETF
                  Fidelity MSCI Health Care Index ETF
                  Picton Mahoney Fortified Long Short Alternative Fund Trust Units
                  Up to five ETFs with an Outperform Smart Score that hold ETNB. The ETFs are listed according to market value of ETNB within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Apellis Pharmaceuticals

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis